Patents by Inventor Jeffrey Brian LOCKE

Jeffrey Brian LOCKE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DOSING REGIMENS FOR TREATMENT OF FUNGAL INFECTIONS
    Publication number: 20240108684
    Abstract: The disclosure features pharmaceutical compositions, methods, and kits featuring dosing regimens and CD101, or a pharmaceutical acceptable salt or neutral form thereof (e.g., CD101 acetate).
    Type: Application
    Filed: June 5, 2023
    Publication date: April 4, 2024
    Inventors: Kenneth BARTIZAL, Paul DARUWALA, Jeffrey Brian LOCKE, Voon ONG, Taylor SANDISON, Dirk THYE
  • Dosing regimens for treatment of fungal infections
    Patent number: 11712459
    Abstract: The disclosure features pharmaceutical compositions, methods, and kits featuring dosing regimens and CD101, or a pharmaceutical acceptable salt or neutral form thereof (e.g., CD101 acetate).
    Type: Grant
    Filed: March 15, 2017
    Date of Patent: August 1, 2023
    Assignee: Cidara Therapeutics, Inc.
    Inventors: Kenneth Bartizal, Paul Daruwala, Jeffrey Brian Locke, Voon Ong, Taylor Sandison, Dirk Thye
  • DOSING REGIMENS FOR TREATMENT OF FUNGAL INFECTIONS
    Publication number: 20190216885
    Abstract: The disclosure features pharmaceutical compositions, methods, and kits featuring dosing regimens and CD101, or a pharmaceutical acceptable salt or neutral form thereof (e.g., CD101 acetate).
    Type: Application
    Filed: March 15, 2017
    Publication date: July 18, 2019
    Inventors: Kenneth BARTIZAL, Paul DARUWALA, Jeffrey Brian LOCKE, Voon ONG, Taylor SANDISON, Dirk THYE
  • METHODS FOR TREATING FUNGAL INFECTIONS
    Publication number: 20180256673
    Abstract: The disclosure relates to methods of treating a fungal infection in a subject by administering to the subject a salt of Compound 1, or a neutral form thereof. The methods of the disclosure can be useful in subjects suffering from treatment resistant infections, useful in subjects who have previously failed treatment with an anti-fungal therapy, and useful for suppressing the emergence of resistant strains in infected subjects.
    Type: Application
    Filed: September 16, 2016
    Publication date: September 13, 2018
    Inventors: James Michael BALKOVEC, Kenneth BARTIZAL, Jeffrey Brian LOCKE, Voon ONG, Taylor SANDISON, Dirk THYE, David S. PERLIN, Kenneth Duke JAMES, Jr.